Australia
Rivalling OpenEvidence and DoxGPT, Heidi’s latest offering, Heidi Evidence, sets itself apart by allowing clinicians to upload their own sources and documents.
Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.
Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.
AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.
Upcoming features include pre-chart summary creation.
Also, Japan has approved one of JLK's stroke imaging AI solutions.
The company has received 12 US FDA approvals.
The Australian-led project developed these maps, claimed to be the most detailed ever made, to link retinal thinning to various diseases.
The funding, which is NRFC's first medical science investment, will help introduce the company's AI to more health facilities locally and abroad.
Also, a new mobile app in Australia tracks eyelid movement to detect sleep apnoea.